Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-25, Stock:PFE, The news for the past five days is as follows:
2019-04-17: NEWS1: Close Update: Healthcare Sector Losses Drag Major Market Indexes Slightly Lower in Wednesday Trading.NEWS2: Close Update: Healthcare Sector Losses Drag Major Market Indexes Slightly Lower in Wednesday Trading.NEWS3: Major Market Indexes Little Changed in Late Wednesday Trading.NEWS4: Major Market Indexes Little Changed in Late Wednesday Trading.NEWS5: Wave Life Sciences Plunges After DMD Study Data Readout.NEWS6: Wave Life Sciences Plunges After DMD Study Data Readout.NEWS7: RSI Alert: Pfizer Now Oversold.NEWS8: RSI Alert: Pfizer Now Oversold.NEWS9: Wave Life Sciences Plunges After DMD Study Data Readout.NEWS10: Pfizer Falls 3%.NEWS11: Health Care Sector Update for 04/17/2019: ONCS, TXMD, ABT, JNJ, PFE, MRK, AMGN.NEWS12: Health Care Sector Update for 04/17/2019: ONCS, TXMD, ABT, JNJ, PFE, MRK, AMGN.
2019-04-18: NEWS1: Pfizer, Lilly shares decline as osteoarthritis drug misses goals in study.NEWS2: Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study.NEWS3: Dow Closes Higher After Retail Sales, Blue-Chip Earnings.NEWS4: Dow Closes Higher After Retail Sales, Blue-Chip Earnings.NEWS5: Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know.NEWS6: Worsening Health-Care Rout Wipes Out $150 Billion in Four Days.NEWS7: Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis.NEWS8: Pharmaceutical ETFs Catch Healthcare Contagion.NEWS9: Market Close Report: NASDAQ Composite index closes at 7,998.06 up 1.98 points.NEWS10: Market Close Report: NASDAQ Composite index closes at 7,998.06 up 1.98 points.NEWS11: Noteworthy Thursday Option Activity: PFE, SBAC, JEC.NEWS12: Noteworthy Thursday Option Activity: PFE, SBAC, JEC.NEWS13: Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders.NEWS14: Can Q1 Earnings Lift Healthcare ETFs Higher?.NEWS15: Can Q1 Earnings Lift Healthcare ETFs Higher?.NEWS16: Clovis Focuses on Rubraca Label Expansion, Competition Stiff.NEWS17: Clovis Focuses on Rubraca Label Expansion, Competition Stiff.NEWS18: Mid-Day Report: US Stocks Mixed as Health Care Sector Clouded by Political Rhetoric While US Retail Sales Jump Most in 18 Mths.NEWS19: Mid-Day Report: US Stocks Mixed as Health Care Sector Clouded by Political Rhetoric While US Retail Sales Jump Most in 18 Mths.NEWS20: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS21: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS22: Markets Right Now: Stocks waver in midday trading.NEWS23: Clovis Focuses on Rubraca Label Expansion, Competition Stiff.NEWS24: Dow Movers: PFE, TRV.NEWS25: Dow Movers: PFE, TRV.NEWS26: Can Q1 Earnings Lift Healthcare ETFs Higher?.NEWS27: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS28: Health Care Sector Update for 04/18/2019: MBIO, EIGR, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS29: Health Care Sector Update for 04/18/2019: MBIO, EIGR, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS30: Health-care stocks keep getting hammered — Wall Street says this is why.
2019-04-22: NEWS1: What's in Store for Bayer (BAYRY) This Earnings Season?.NEWS2: What's in Store for Bayer (BAYRY) This Earnings Season?.NEWS3: Exact Sciences Is Near an All-Time High: Here's Why It Could Go Even Higher.NEWS4: Exact Sciences Is Near an All-Time High: Here's Why It Could Go Even Higher.NEWS5: Exact Sciences Is Near an All-Time High: Here&apos;s Why It Could Go Even Higher.NEWS6: What's in Store for Bayer (BAYRY) This Earnings Season?.NEWS7: JNJ or PFE: Comparing Legacy and Newly Launched Immunology Drugs.NEWS8: Monday’s Vital Data: Pfizer, Canopy Growth Corp and Microsoft.NEWS9: Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?.NEWS10: Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?.NEWS11: Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?.NEWS12: Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?.NEWS13: JNJ or PFE: Comparing Their Fastest-Growing Immunology Drugs.NEWS14: JNJ or PFE: Comparing Fastest Growing Immunology Drugs.NEWS15: Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?.NEWS16: Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns.NEWS17: Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?.NEWS18: Pfizer Stock Suffers From an Underappreciated Drugs Pipeline.NEWS19: What to Expect from Pfizer’s Revenue and Earnings in Q1.NEWS20: Health Care Sector Update for 04/22/2019: ISRG, AXGN, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS21: Health Care Sector Update for 04/22/2019: ISRG, AXGN, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS22: JNJ or PFE: Which Has Better EPS Guidance for 2019?.NEWS23: JNJ or PFE: Who has a Stronger EPS Guidance for Fiscal 2019?.NEWS24: Monday’s Vital Data: Pfizer, Canopy Growth Corp and Microsoft.NEWS25: What Affected Pfizer’s Stock Price Last Week?.NEWS26: JNJ or PFE: Who has a Stronger Revenue Guidance for Fiscal 2019?.NEWS27: Merck's Keytruda wins FDA approval as combination therapy for kidney cancer.NEWS28: Pfizer Stock Suffers From an Underappreciated Drugs Pipeline.
2019-04-23: NEWS1: 6 Poorly Performing Stocks in Gurus' Portfolios.NEWS2: Kidney-Cancer Market: Good for Patients, Hard for Investors.NEWS3: Kidney-Cancer Market: Good for Patients, Hard for Investors.NEWS4: Kidney-Cancer Market: Good for Patients, Hard for Investors.NEWS5: Why Is Bristol-Myers Near 52-Week Lows?.NEWS6: Why Is Bristol-Myers Near 52-Week Lows?.NEWS7: Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release.NEWS8: Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release.NEWS9: Amgen (AMGN) to Report Q1 Earnings: What's in the Cards?.NEWS10: Amgen (AMGN) to Report Q1 Earnings: What's in the Cards?.NEWS11: Alexion (ALXN) to Report Q1 Earnings: What's in the Cards?.NEWS12: Alexion (ALXN) to Report Q1 Earnings: What's in the Cards?.NEWS13: Why Is Bristol-Myers Near 52-Week Lows?.NEWS14: Amgen (AMGN) to Report Q1 Earnings: What's in the Cards?.NEWS15: Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release.NEWS16: Health Care Sector Update for 04/23/2019: LENS, MBRX, WAT, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Health Care Sector Update for 04/23/2019: LENS, MBRX, WAT, JNJ, PFE, ABT, MRK, AMGN.NEWS18: Alexion (ALXN) to Report Q1 Earnings: What's in the Cards?.
2019-04-24: NEWS1: Lannett (LCI) to Report Q3 Earnings: What's in the Cards?.NEWS2: Lannett (LCI) to Report Q3 Earnings: What's in the Cards?.NEWS3: Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates?.NEWS4: Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates?.NEWS5: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS6: After Hours Most Active for Apr 24, 2019 :  PCG, MSFT, FB, SNAP, CMCSA, XOG, FOLD, SHY, PFE, RF, CNDT, POL.NEWS7: After Hours Most Active for Apr 24, 2019 :  PCG, MSFT, FB, SNAP, CMCSA, XOG, FOLD, SHY, PFE, RF, CNDT, POL.NEWS8: Lannett (LCI) to Report Q3 Earnings: What's in the Cards?.NEWS9: Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates?.NEWS10: Why Investors Should Buy the Dip in MRK Stock.NEWS11: Health Care Sector Update for 04/24/2019: ANTM, RAD, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 04/24/2019: ANTM, RAD, JNJ, PFE, ABT, MRK, AMGN.NEWS13: What Are Analysts Recommending for Merck?.NEWS14: AstraZeneca chief claims vindication five years after Pfizer bid.

Answer: Rise